Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes / Jasmin Herz, Julian Pardo, Hamid Kashkar, Michael Schramm, Elza Kuzmenkina, Erik Bos, Katja Wiegmann, Reinhard Wallich, Peter J. Peters, Stefan Herzig, Elmon Schmelzer, Martin Krönke, Markus M. Simon & Olaf Utermöhlen
Granule-mediated cytotoxicity is the main effector mechanism of cytotoxic CD8+ T cells. We report that CD8+ T cells from acid sphingomyelinase (ASMase)-deficient (ASMase-KO) mice are defective in exocytosis of cytolytic effector molecules; this defect resulted in attenuated cytotoxic activity of ASMase-KO CD8+ T cells and delayed elimination of lymphocytic choriomeningitis virus from ASMase-KO mice. Cytolytic granules of ASMase-KO and wild-type CD8+ T cells were equally loaded with granzymes and perforin, and correctly directed to the immunological synapse. In wild-type CD8+ T cells, secretory granules underwent shrinkage by 82% after fusion with the plasma membrane. In ASMase-KO CD8+ T cells, the contraction of secretory granules was markedly impaired. Thus, ASMase is required for contraction of secretory granules and expulsion of cytotoxic effector molecules..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
14 June 2009 2009 |
---|---|
Erschienen: |
14 June 2009 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Nature immunology - 10(2009), 7, Seite 761-768 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Herz, Jasmin, 1979- [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Gesehen am 17.05.2021 |
---|
Umfang: |
8 |
---|
doi: |
10.1038/ni.1757 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1757914919 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1757914919 | ||
003 | DE-627 | ||
005 | 20230428185608.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210517s2009 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/ni.1757 |2 doi | |
035 | |a (DE-627)1757914919 | ||
035 | |a (DE-599)KXP1757914919 | ||
035 | |a (OCoLC)1341413209 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Herz, Jasmin |d 1979- |e verfasserin |0 (DE-588)137063326 |0 (DE-627)589474081 |0 (DE-576)301530785 |4 aut | |
245 | 1 | 0 | |a Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes |c Jasmin Herz, Julian Pardo, Hamid Kashkar, Michael Schramm, Elza Kuzmenkina, Erik Bos, Katja Wiegmann, Reinhard Wallich, Peter J. Peters, Stefan Herzig, Elmon Schmelzer, Martin Krönke, Markus M. Simon & Olaf Utermöhlen |
264 | 1 | |c 14 June 2009 | |
300 | |a 8 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 17.05.2021 | ||
520 | |a Granule-mediated cytotoxicity is the main effector mechanism of cytotoxic CD8+ T cells. We report that CD8+ T cells from acid sphingomyelinase (ASMase)-deficient (ASMase-KO) mice are defective in exocytosis of cytolytic effector molecules; this defect resulted in attenuated cytotoxic activity of ASMase-KO CD8+ T cells and delayed elimination of lymphocytic choriomeningitis virus from ASMase-KO mice. Cytolytic granules of ASMase-KO and wild-type CD8+ T cells were equally loaded with granzymes and perforin, and correctly directed to the immunological synapse. In wild-type CD8+ T cells, secretory granules underwent shrinkage by 82% after fusion with the plasma membrane. In ASMase-KO CD8+ T cells, the contraction of secretory granules was markedly impaired. Thus, ASMase is required for contraction of secretory granules and expulsion of cytotoxic effector molecules. | ||
650 | 4 | |a Animals | |
650 | 4 | |a Arenaviridae Infections | |
650 | 4 | |a CD8-Positive T-Lymphocytes | |
650 | 4 | |a Chemokine CCL5 | |
650 | 4 | |a Cytotoxicity, Immunologic | |
650 | 4 | |a Female | |
650 | 4 | |a Granzymes | |
650 | 4 | |a Immunoblotting | |
650 | 4 | |a Immunological Synapses | |
650 | 4 | |a Lymphocytic choriomeningitis virus | |
650 | 4 | |a Male | |
650 | 4 | |a Mice | |
650 | 4 | |a Mice, Knockout | |
650 | 4 | |a Microscopy, Fluorescence | |
650 | 4 | |a Perforin | |
650 | 4 | |a Reverse Transcriptase Polymerase Chain Reaction | |
650 | 4 | |a Secretory Vesicles | |
650 | 4 | |a Sphingomyelin Phosphodiesterase | |
650 | 4 | |a T-Lymphocytes | |
650 | 4 | |a T-Lymphocytes, Cytotoxic | |
700 | 1 | |a Pardo, Julian |e verfasserin |4 aut | |
700 | 1 | |a Kashkar, Hamid |e verfasserin |4 aut | |
700 | 1 | |a Schramm, Michael |e verfasserin |4 aut | |
700 | 1 | |a Kuzmenkina, Elza |e verfasserin |4 aut | |
700 | 1 | |a Bos, Erik |e verfasserin |4 aut | |
700 | 1 | |a Wiegmann, Katja |e verfasserin |4 aut | |
700 | 1 | |a Wallich, Reinhard |e verfasserin |0 (DE-588)1059566710 |0 (DE-627)798640839 |0 (DE-576)163467781 |4 aut | |
700 | 1 | |a Peters, Peter J. |e verfasserin |4 aut | |
700 | 1 | |a Herzig, Stefan |e verfasserin |4 aut | |
700 | 1 | |a Schmelzer, Elmon |e verfasserin |4 aut | |
700 | 1 | |a Krönke, Martin |e verfasserin |4 aut | |
700 | 1 | |a Simon, Markus M. |e verfasserin |4 aut | |
700 | 1 | |a Utermöhlen, Olaf |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature immunology |d London : Springer Nature Limited, 2000 |g 10(2009), 7, Seite 761-768 |h Online-Ressource |w (DE-627)32360790X |w (DE-600)2026412-4 |w (DE-576)099426641 |x 1529-2916 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2009 |g number:7 |g pages:761-768 |g extent:8 |
856 | 4 | 0 | |u https://doi.org/10.1038/ni.1757 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u https://www.nature.com/articles/ni.1757 |x Verlag |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_90 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_121 | ||
912 | |a GBV_ILN_138 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_152 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_171 | ||
912 | |a GBV_ILN_187 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_224 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_370 | ||
912 | |a GBV_ILN_374 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_603 | ||
912 | |a GBV_ILN_647 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2026 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2031 | ||
912 | |a GBV_ILN_2034 | ||
912 | |a GBV_ILN_2037 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2043 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2050 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2056 | ||
912 | |a GBV_ILN_2057 | ||
912 | |a GBV_ILN_2059 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a GBV_ILN_2088 | ||
912 | |a GBV_ILN_2093 | ||
912 | |a GBV_ILN_2108 | ||
912 | |a GBV_ILN_2110 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_2112 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2116 | ||
912 | |a GBV_ILN_2118 | ||
912 | |a GBV_ILN_2119 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a GBV_ILN_2143 | ||
912 | |a GBV_ILN_2147 | ||
912 | |a GBV_ILN_2148 | ||
912 | |a GBV_ILN_2152 | ||
912 | |a GBV_ILN_2153 | ||
912 | |a GBV_ILN_2158 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2193 | ||
912 | |a GBV_ILN_2336 | ||
912 | |a GBV_ILN_2472 | ||
912 | |a GBV_ILN_2522 | ||
912 | |a GBV_ILN_2911 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4046 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4242 | ||
912 | |a GBV_ILN_4246 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4251 | ||
912 | |a GBV_ILN_4277 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4326 | ||
912 | |a GBV_ILN_4328 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4336 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4346 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4393 | ||
912 | |a GBV_ILN_4700 | ||
912 | |a GBV_ILN_4753 | ||
936 | u | w | |d 10 |j 2009 |e 7 |h 761-768 |g 8 |
951 | |a AR | ||
952 | |d 10 |j 2009 |e 7 |h 761-768 |g 8 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3929014289 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 17-05-21 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2009 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_14 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_8 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1485706335 |a Wallich, Reinhard | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416741488 |a Institut für Immunologie und Serologie | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_8 |